Mersana Therapeutics, Inc. (NASDAQ:MRSN) Q1 2025 Earnings Call Transcript May 15, 2025
Operator: Good morning, and welcome to Mersana Therapeutics First Quarter 2025 Conference Call. Currently all participants are in a listen-only mode. There will be a question-and-answer session at the end of this call. [Operator Instructions] I would now like to turn the call over to Mr. Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please proceed, sir.
Jason...
